What question did this study set out to answer?

This study investigates how travel time to cancer care affects access, transportation distress, and financial toxicity.

Travel time to cancer care as it relates to care access, transportation distress, and financial toxicity: Findings from the Cancer Experience Registry.

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial examines travel time impact on care access, distress, and financial toxicity in cancer patients, suggesting improvements are needed.

This study investigates how travel time to cancer care affects access, transportation distress, and financial toxicity.
Participants reported sociodemographic data, financial toxicity, travel time, and transportation distress.
Descriptive findings and Chi-square analyses were utilized to explore relationships between variables.
Data are from Cancer Support Community’s Cancer Experience Registry between Oct 2021 and Dec 2025.
29% of participants experienced delays in cancer care, increasing with travel time (24% for <1hr vs. 46% for 5+hrs, χ²=84.3, p<.001).
Transportation-related distress grows with travel duration (84% no concern for <1hr vs. 60% for 5+hrs, χ²=167.9, p<.001).
Financial toxicity rises with travel burden: 43% of <1hr travelers report mild-to-severe toxicity versus 64% for 5+hrs (χ²=63.7, p<0.001).

Fortune et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial examines travel time impact on care access, distress, and financial toxicity in cancer patients, suggesting improvements are needed.